CTNM
ANALYST COVERAGE3 analysts
BUY
+4.4%upside to target
L $14.00
Med $15.00consensus
H $16.00
Buy
267%
Hold
133%
2 Buy (67%)1 Hold (33%)0 Sell (0%)
Full report →
PRICE
Prev Close
13.39
Open
13.40
Day Range13.21 – 14.43
13.21
14.43
52W Range3.35 – 16.33
3.35
16.33
85% of range
VOLUME & SIZE
Avg Volume
276.1K
FUNDAMENTALS
P/E Ratio
-7.4x
Not profitable
EPS (TTM)
Div Yield
No dividend
TECHNICAL
RSI (14)
43
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19

CTNM News

About

No description available.

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Peter T. SloverChief Financial Officer
Steve E. KunszaboSenior Director of Investor Relations & Corporate Communications
Jennifer PattersonVice President of Human Resources
Julie S. IwashitaSenior Vice President of Clinical Operations
Kristina Haeckl RacSenior Vice President of Regulatory Affairs
Daniel S. LorrainChief Science Officer
Timothy R. WatkinsChief Medical Officer & Head of Development
Austin ChenSenior Vice President & Head of Research
Carmine N. StengonePresident, Chief Executive Officer & Director
John HealyGeneral Counsel & Corporate Secretary
Morgan PaulsenSenior Manager of Accounting